1-(2-Propan-2-ylphenyl)piperidine | 97053-12-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 1-(2-Propan-2-ylphenyl)piperidine
• CAS: 97053-12-8
• 化学式: C₁₄H₂₁N
• 分子量: 203.327
• InChiKey: HDCYQTWLQZGCRQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  2-异丙基苯胺 在 硼烷 、 sodium acetate 、 乙酸酐 作用下， 以 四氢呋喃 为溶剂， 生成 1-(2-Propan-2-ylphenyl)piperidine
  参考文献：
  名称：

  A Convenient Synthesis of HinderedN-Aryl Substituted Cyclic Amines

  摘要：

  An efficient and high yielding synthesis of N-substituted pyrrolidines and piperidines is described.

  DOI：

  10.1080/00397919808007182

文献信息

• [EN] BCL-2 INHIBITOR<br/>[FR] INHIBITEUR DE BCL -2
  申请人：BEIGENE LTD

  公开号：WO2021208963A1

  公开（公告）日：2021-10-21

  Disclosed herein is a compound of Formula (I) for inhibiting both Bcl-2 wild type and mutated Bcl-2, in particular, Bcl-2 G101V and D103Y, and a method of using the compound disclosed herein for treating dysregulated apoptotic diseases.

  本文披露了一种用于抑制Bcl-2野生型和突变型Bcl-2（特别是Bcl-2 G101V和D103Y）的化合物（I）以及使用本文披露的该化合物治疗失调的凋亡性疾病的方法。
• [EN] BROAD SPECTRUM ANTI-CANCER COMPOUNDS<br/>[FR] COMPOSÉS ANTICANCÉREUX À LARGE SPECTRE
  申请人：UNIV CALIFORNIA

  公开号：WO2021076617A1

  公开（公告）日：2021-04-22

  Described herein, inter alia, are compounds for treating cancer and methods of use. This disclosure features chemical entities (e.g., small hairpin RNAs (shRNAs), micro RNA (miRNAs), small interfering RNA (siRNAs), small molecule inhibitors, antisense nucleic acids, peptides, viruses, CRISPR-sgRNAs, or combinations thereof) that inhibit one or more of m6A writers (e.g., methyltransferase like 3 (Mettl3 or MT-A70) or methyltransferase like-14 (Mettl14)), m6Am writers (e.g., phosphorylated CTD interacting factor I (PCIF 1), or Mettl3/14), m6A erasers (e.g., fat-mass and obesity-associated protein (FTO) or ALKB homolog 5 (ALKBH5)), m6Am erasers (e.g., FTO), m6A readers (e.g., YTH domain-containing family proteins (YTHs)), YTF domain family member 1 (YTHDF 1), YTF domain family member 2 (YTHDF 2), YTF domain family member 3 (YTHDF 3), or tyrosine-protein phosphatase non-receptor type 2 (PTPN2).

  本文描述了用于治疗癌症的化合物和使用方法。该公开涉及抑制m6A编写酶（例如，甲基转移酶类3（Mettl3或MT-A70）或甲基转移酶类14（Mettl14））、m6Am编写酶（例如，磷酸化CTD相互作用因子I（PCIF 1）或Mettl3/14）、m6A擦除酶（例如，脂肪质量和肥胖相关蛋白（FTO）或ALKB同源物5（ALKBH5））、m6Am擦除酶（例如，FTO）、m6A读取器（例如，YTH结构域含家族蛋白（YTHs））、YTF结构域家族成员1（YTHDF 1）、YTF结构域家族成员2（YTHDF 2）、YTF结构域家族成员3（YTHDF 3）或酪氨酸蛋白磷酸酶非受体型2（PTPN2）等化学实体（例如，小发夹RNA（shRNAs）、微RNA（miRNAs）、小干扰RNA（siRNAs）、小分子抑制剂、反义核酸、肽、病毒、CRISPR-sgRNAs或其组合）。
• Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
  申请人：Zhang Xiaojun

  公开号：US20070003539A1

  公开（公告）日：2007-01-04

  The present invention provides novel phenylglycinamide derivatives of Formula (I) or (IV): or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables W, W 1 , Y, Z, R 7 , R 8 , R 9 , and R 11 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.

  本发明提供了式(I)或(IV)的新型苯基甘氨酰衍生物：或其立体异构体、互变异构体、药学上可接受的盐、溶剂合物或前药，其中变量W、W1、Y、Z、R7、R8、R9和R11如本文所定义。这些化合物是选择性因子VIIa的抑制剂，可用作药物。
• Synthesis of sterically hindered 1-arylpyrrolidines and 1-arylpiperidines by condensation of primary aromatic amines with cyclic ethers or diols
  作者：Robert E. Walkup、Scott Searles

  DOI：10.1016/s0040-4020(01)83473-6

  日期：1985.1

  1-(-'-dialkylphenyl)- pyrrolidines and -piperidines were prepared by the gas phase alumina mediated condensation of tetrahydrofuran (THF), tetrahydropyran (THP) or the corresponding diols with primary aromatic amines in fair to high yield. This methodology can also be used for the synthesis of 1-phenylhexahydroazepine from aniline. A mechanistic interpretation of the catalytic action of alumina is presented

  通过气相氧化铝介导的四氢呋喃（THF），四氢吡喃（THP）或相应的二醇与伯芳香族化合物的缩合反应，制备了各种1 -（-烷基苯基）-和1 - （-'-二烷基苯基）-吡咯烷和-哌啶胺以中等至高收率获得。该方法也可以用于由苯胺合成1-苯基六氢氮杂pine。提出了对氧化铝催化作用的机械解释。
• Borane-Catalyzed Synthesis of Quinolines Bearing Tetrasubstituted Stereocenters by Hydride Abstraction-Induced Electrocyclization
  作者：Alexander F. G. Maier、Sebastian Tussing、Hui Zhu、Garrit Wicker、Pavleta Tzvetkova、Ulrich Flörke、Constantin G. Daniliuc、Stefan Grimme、Jan Paradies

  DOI：10.1002/chem.201804777

  日期：2018.11.2

  stereocenters from vinyl anilines has been developed. Mechanistic studies and quantum‐mechanical investigations support the hydride abstraction/electrocyclization/hydride addition mechanism. The products were obtained in up to 99 % yield with a diastereoselectivity of >99 % in favour for the 3a‐5‐cis isomer.

  已开发出硼烷催化的由乙烯基苯胺合成带有四取代立体中心的喹啉衍生物。力学研究和量子力学研究支持氢化物提取/电环化/氢化物加成机理。获得的产品收率高达99％，非对映选择性> 99％，有利于3a-5-顺式异构体。